Should women under 50 be screened for breast cancer?

British Journal of Cancer

Volumn 91, Issue 3, 2004, Pages 413-417

  Moss, S ^a  

^a Evaluation Unit   (United Kingdom)

Author keywords

Breast cancer; Mammography; Screening

Indexed keywords

BREAST CANCER; BREAST EXAMINATION; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER PREVENTION; CANCER RESEARCH; CANCER SCREENING; FEMALE; HEALTH CARE COST; HEALTH CARE POLICY; HIGH RISK POPULATION; HUMAN; MAMMOGRAPHY; PRIORITY JOURNAL; RADIATION EXPOSURE; SHORT SURVEY;

ADULT; AGE FACTORS; BREAST NEOPLASMS; COST-BENEFIT ANALYSIS; FALSE POSITIVE REACTIONS; FEMALE; HEALTH CARE COSTS; HEALTH POLICY; HUMANS; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; PRACTICE GUIDELINES; RANDOMIZED CONTROLLED TRIALS;

EID: 4143061668     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6601966     Document Type: Short Survey

References (52)

1. Alexander FE, Anderson TJ, Brown HK, Forrest AP, Hepburn W, Kirkpatrick AE, Muir BB, Prescott RJ, Smith A (1999) 14 years of follow-up from the Edinburgh randomised trial of breast-cancer screening. Lancet 353: 1903-1908
2. Anderson TJ, Alexander FE, Lamb J, Smith A, Forrest AP (2000) Pathology characteristics that optimize outcome prediction of a breast screening trial. Br J Cancer 83: 487-492
3. Andersson I, Janzon L (1997) Reduced breast cancer mortality in women under age 50: updated results from the Malmo Mammographic Screening Program. J Natl Cancer Inst Monogr 22: 63-67
4. Baines CJ (2003) Mammography screening: are women really giving informed consent? J Natl Cancer Inst 95: 1508-1511
5. Baum M (1996) The breast screening controversy. Eur J Cancer 32A: 9-11
6. Bjurstam N, Bjorneld L, Duffy SW, Smith TC, Cahlin E, Eriksson O, Hafstrom LO, Lingaas H, Mattsson J, Persson S, Rudenstam C-M, Save-Soderbergh J (1997) The Gothenburg Breast Screening Trial: First Results on Mortality, Incidence, and Mode of Detection for Women Ages 39-49 Years at Randomization. Cancer 80: 2091-2099
7. Cockburn J, Staples M, Hurley SF, De Luise T (1994) Psychological consequences of screening mammography. J Med Screening 1: 7-12
8. de Haes JCJM, de Koning HJ, van Oortmarssen GJ, van Agt HME, de Bruyn AE, van der Maas PJ (1991) The impact of a breast cancer screening programme on quality-adjusted life-years. Int J Cancer 49: 538-544
9. de Koning HJ, Boer R, Warmerdam PG, Beemsterboer PMM, van der Maas PJ (1995) Quantitative interpretation of age-specific mortality reductions from the Swedish breast cancer-screening trials. J Natl Cancer Inst 87: 1217-1223
10. Eeles RA (1999) Screening for hereditary cancer and genetic testing, epitomised by breast cancer. Eur J Cancer 35: 1954-1962
11. Ellman R, Thomas BA (1995) Is psychological well being impaired in long term survivors of breast cancer? J Med Screening 2: 5-9
12. Elmore J, Wells C, Howard D (1998) Does diagnostic accuracy in mammography depend on radiologists' experience? J Women Health 7: 443-449
13. Evans AJ, Pinder SE, Ellis IO, Wilson ARM (2001) Screen detected ductal carcinoma in situ (DCIS): overdiagnosis or an obligate precursor of invasive disease? J Med Screening 8: 149-151
14. Feig SA, Hendrick RE (1997) Radiation risk from screening mammography of women aged 40-49 years. J Natl Cancer Inst Monogr 22: 119-124
15. Hendrick RE, Smith RA, Rutledge JH, Smart CR (1997) Benefit of screening mammography in women aged 40-49; a new meta-analysis of randomized controlled trials. Monogr Natl Cancer Inst 22: 87-92
16. Houlston RS, McCarter E, Parbhoo S, Scurr JH, Slack J (1992) Family history and risk of breast cancer. J Med Genet 29: 154-157
17. Jatoi I, Baum M (1995) Mammographically detected ductal carcinoma in situ: are we overdiagnosing breast cancer? Surgery 118: 118-120
18. Kerlikowske K, Grady D, Rubin SM, Sandrock C, Ernster VL (1995) Efficacy of screening mammography. A meta-analysis. JAMA 273: 149-154
19. Kopans DB (1998) The mammography screening controversy. Cancer J Sci Am 4: 22-24
20. Kopans DB, Halpern E, Hulka CA (1994) Statistical power in breast cancer screening trials and mortality reduction among women 40-49 years of age with particular emphasis on the National Breast Screening Study of Canada. Cancer 74: 1196-1216
21. Lampic C, Thurfjell E, Bergh J, Sjoden P-O (2001) Short- and long-term anxiety and depression in women recalled after breast cancer screening. Eur J Cancer 37: 463-469
22. Law J, Faulkner K. (2001) Cancers detected and induced, and associated risk and benefit, in a breast screening programme. Br J Radiol 74: 1121-1127
23. Law J (1995) Risk and benefit associated with radiation dose in breast screening programmes - an update. Br J Radiol 68: 870-876
24. Lerman C, Trock B, Rimer BK, Boyce A (1991) Psychological and behavioural implications of abnormal mammograms. American College of Physicians - Am Soc Int Med 114: 657-661
25. Lidbrink E, Elfving J, Frisell J, Jonsson E (1996) Neglected aspects of false positive findings of mammography in breast cancer screening: analysis of false positive cases from the Stockholm trial. BMJ 312: 273-276
26. Lightfoot N, Steggles S, Wilkinson D, Bissett R, Bakker D, Darlington G, Erola K, Miller D (1994) The short-term psychological impact of organised breast cancer screening. Curr Oncol 1: 206-211
27. Lindfors KK, Rosenquist CJ (1995) The cost-effectiveness of mammographic screening strategies. JAMA 274: 881-884
28. MacKay J, Rogers C, Fielder H, Blamey R, MacMillan D, Boggis CR, Brown J, Pharoah PD, Moss S, Day NE, Myles J, Austoker J, Gray J, Cuzick J, Duffy SW (2001) Development of a protocol for evaluation of mammographic surveillance services in women under 50 with a family history of breast cancer. J Epidemiol Biostat 6: 365-369
29. Miller AB, Baines CJ, To T, Wall C (1992) Canadian National Breast Screening Study: 1. Breast cancer detection and death rates among women aged 40 to 49 years. Can Med Assoc J 147: 1459-1476
30. Miller AB, To T, Baines CJ, Wall C (2002) The Canadian National Breast Screening Study-1: breast cancer mortality after 11 to 16 years of follow-up. Ann Intern Med 137: E-305-E-315
31. Moss S, for the Trial Steering Group (1999) A trial to study the effect on breast cancer mortality of annual mammographic screening in women starting at age 40. J Med Screening 6: 144-148
32. Narod S (1997) On being the right size: a reappraisal of mammography trials in Canada and Sweden. Lancet 349: 1846
33. Nystrom L, Andersson I, Bjurstam N, Frisell J, Nordenskjold B (2002) Long-term effects of mammography screening: updated overview of the Swedish randomised trials. Lancet 359: 909-919
34. Ringash J (2001) Preventive health care, 2001 update: screening mammography among women aged 40-49 years at average risk of breast cancer. Can Med Assoc J 164: 469-476
35. Salzmann P, Kerlikowske K, Phillips K (1997) Cost-effectiveness of extending screening mammography guidelines to include women 40 to 49 years of age. Arch Intern Med 127: 955-965
36. Sasieni P, Cuzick J (2003) The UK breast-screening programme should start at age 47 years. Lancet 362: 247
37. Shapiro S, Coleman EA, Broeders M, Codd M, de Koning H, Fracheboud J, Moss S, Paci E, Stachenko S, Ballard-Barbash R (1998) For the International Breast Cancer Screening Network (IBSN) and the European Network of Pilot Projects for Breast Cancer Screening. Breast cancer screening programmes in 22 countries: current policies, administration and guidelines. Int J Epidemiol 27: 735-742
38. Shapiro S, Venet W, Strax P, Venet L (1988) Periodic Screening for Breast Cancer. Baltimore & London: Johns Hopkins University Press
39. Smart CR, Hendrick RE, Rutledge JHI, Smith RA (1995) Benefit of mammography screening in women ages 40 to 49 years. Current evidence from randomized controlled trials. Cancer 75: 1619-1626
40. Smith A, Saslow D, Sawyer K, Burke W, Costanza M, Evans III W, Foster Jr RS, Hendrick E, Eyre H, Sener S (2003) American Cancer Society guidelines for breast cancer screening: update 2003. Can J Clin 53: 141-169
41. Swift M, Morrell D, Massey RB, Chase CI (1991) Incidence of cancer in 161 families affected by ataxia-telangiectasia. N Engl J Med 325: 1831-1836
42. Tabar L, Fagerberg G, Chen HH, Duffy SW, Gad A (1995) Screening for breast cancer in women aged under 50: mode of detection, incidence, fatality and histology. J Med Screening 2: 94-98
43. Tabar L, Fagerberg G, Duffy SW, Day NE, Gad A, Grontoft O (1992) Update of the Swedish two-county program of mammographic screening for breast cancer. Radiol Clin North Am 30: 187-210
44. Tabar L, Vitak B, Chen HH, Duffy SW, Yen MF, Chiang CF, Krusemo UB, Tot T, Smith RA (2000) The Swedish Two-County Trial twenty years later. Updated mortality results and new insights from long-term follow-up. Radiol Clin North Am 38: 625-651
45. Teh W, Wilson ARM (1998) The role of ultrasound in breast cancer screening. A consensus statement by the European Group for Breast Cancer Screening. Eur J Cancer 34: 449-450
46. The UK MRI Breast Screening Study Advisory Group (2000) (Brown J, Coulthard A, Dixon AK, Dixon JM, Easton DF, Eeles RA, Evans DGR, Moss SM) Protocol for a national multi-centre study of magnetic resonance imaging screening in women at genetic risk of breast cancer. Breast 9: 78-82
47. Thornton H, Edwards A, Baum M (2003) Women need better information about routine mammography. BMJ 327: 101-103
48. U.S. Preventive Services Task Force (2002) Screening for breast cancer: recommendations and rationale. Ann Intern Med 137: 344-346
49. Wagner LK (1992) To the Editor. N Engl J Med 326: 1358
50. Walker L, Cordiner C, Gilbert F, Needham G, Deans H, Affleck I, Hood D, Mathieson D, Ah-See A, Eremin O (1994) How distressing is attendance for routine breast screening? Psy-Oncol 3: 299-304
51. Warner E, Plewes DB, Shumak RS, Catzavelos GC, Di Prospero LS, Yaffe MJ, Goel V, Ramsay E, Chart PL, Cole DE, Taylor GA, Cutrara M, Samuels TH, Murphy JP, Murphy JM, Narod SA (2001) Comparison of breast magnetic resonance imaging, mammography, and ultrasound for surveillance of women at high risk for hereditary breast cancer. J Clin Oncol 19: 3524-3531
52. Young KC (2001) Radiation doses in the United Kingdom trial of breast screening in women aged 40 to 48. Br J Radiol 75: 362-370